Powered by: Motilal Oswal
2026-01-07 03:46:46 pm | Source: Accord Fintech
Chemfab Alkalis zooms on commissioning latest generation INEOS Electrolyser
Chemfab Alkalis zooms on commissioning latest generation INEOS Electrolyser

Chemfab Alkalis is currently trading at Rs. 443.70, up by 22.70 points or 5.39% from its previous closing of Rs. 421.00 on the BSE.

The scrip opened at Rs. 425.20 and has touched a high and low of Rs. 450.00 and Rs. 422.05 respectively. So far 2493 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1060.05 on 09-Jan-2025 and a 52 week low of Rs. 397.35 on 31-Dec-2025.

Last one week high and low of the scrip stood at Rs. 468.80 and Rs. 410.00 respectively. The current market cap of the company is Rs. 637.76 crore.

The promoters holding in the company stood at 72.18%, while Institutions and Non-Institutions held 0.33% and 27.48% respectively.

Chemfab Alkalis has successfully commissioned the latest generation INEOS Electrolyser with the requisite consent and approval to operate the same replacing the existing 30-year-old second-Generation UHDE Electrolyser and associated equipment to improve overall efficiency and optimise costs. The consent capacity remains at 180 tonnes per day.

The replacement is expected to enhance operating rate with better reliability. The company also expects power savings from Q4 of the Financial Year 2025-26. The company has invested around Rs 57 crore in this project, which was funded through internal accruals.

Chemfab Alkalis is in the business of manufacturing of basic inorganic chemicals.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here